Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
31 participants
INTERVENTIONAL
2018-04-01
2021-03-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sleep Patterns in Children With and Without Juvenile Idiopathic Arthritis
NCT01434082
Fragmented Sleep, Pain, and Biomechanics
NCT06336109
Sleep Extension and Insulin Sensitivity in Adolescents
NCT03754036
Sleep After Adolescent Concussion
NCT03781076
Total Joint Arthroplasty and Sleep
NCT03968939
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Restricted sleep condition first, longer sleep condition second
Sleep Manipulation Protocol
A structured sleep duration intervention will be taught to patients
Group 2
Longer sleep condition first, restricted sleep condition second
Sleep Manipulation Protocol
A structured sleep duration intervention will be taught to patients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sleep Manipulation Protocol
A structured sleep duration intervention will be taught to patients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* all subtypes of JIA, as per the ILAR criteria
* a baseline pain score of ≥ 1 on a visual analogue scale
* age from 12-18 years old
* capable of providing informed consent form themselves, as judged by the clinical team
Exclusion Criteria
* a high probability of having obstructive sleep apnea as determined by the Pediatric Sleep Questionnaire
* currently taking medication with the intent to impact sleep (e.g., zolpidem, benzodiazepines, etc.)
* taking corticosteroids (which may adversely affect sleep)
* obligations that require a bed time later than 10:00 pm or a wake time earlier than 5:30 am during the study period
* daily consumption of \> 1 coffee or "energy drink" and/or \> 3 caffeinated carbonated beverages
* do not speak/understand English with enough proficiency to complete all study related tasks, as judged by the clinical team
12 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital Medical Center, Cincinnati
OTHER
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
The Hospital for Sick Children
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Brian Feldman
Division Head, Division of Rheumatology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Hospital for Sick Children
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Clairman H, Dover S, Tomlinson G, Beebe D, Cameron B, Laxer RM, Levy D, Narang I, Paetkau S, Schneider R, Spiegel L, Stephens S, Stinson J, Tse S, Weiss S, Whitney K, Feldman BM. Lengthening sleep reduces pain in childhood arthritis: a crossover randomised controlled trial. RMD Open. 2023 Oct;9(4):e003352. doi: 10.1136/rmdopen-2023-003352.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1000061386
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.